Literature DB >> 1259401

In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.

A Vuye, J Pijck, H Soep.   

Abstract

The in vitro activity of BL-S640 (cefatrizine) was determined against 674 recent clinical isolates of Staphylococcus aureus and Enterobacteriaceae. Activity against S. aureus was less than that of cephapirin, cephalothin, and cefazolin, but greater than that of cephalexin. Activity against gram-negative isolates was variable: BL-S640 was slightly less potent than cefazolin against Escherichia coli and Klebsiella, but more active than the other compounds. As for the more resistant gram-negative genera, BL-S640 was significantly superior to the control cephalosporins. The effect of inoculum size on the antibacterial activity was moderate for most organisms except Enterobacter, Providencia stuartii, and indole-positive Proteus, the median minimal inhibitory concentrations of which were 6 to 27 times lower when determined with a 10(-4)-diluted culture compared with the undiluted one. The stability in aqueous solution at 37 C was remarkably high at the lower pH values, but low at the neutral point.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259401      PMCID: PMC429547          DOI: 10.1128/AAC.9.3.422

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  CEPHALOTHIN--A NEW ANTIBIOTIC. PRELIMINARY CLINICAL AND LABORATORY STUDIES.

Authors:  R S GRIFFITH; H R BLACK
Journal:  JAMA       Date:  1964-09-14       Impact factor: 56.272

2.  BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.

Authors:  F Leitner; R E Buck; M Misiek; T A Pursiano; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.

Authors:  C Watanakunakorn; T Bannister; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

Review 4.  Cephalexin.

Authors:  R S Griffith; H R Black
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

5.  Comparative stabilities of cephalosporins in aqueous solution.

Authors:  T Yamana; A Tsuji; K Kanayama; O Nakano
Journal:  J Antibiot (Tokyo)       Date:  1974-12       Impact factor: 2.649

6.  In vitro activity of cefazolin against recent clinical bacterial isolates.

Authors:  L D Sabath; C Wilcox; C Garner; M Finland
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

7.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

8.  Cephapirin: in vitro antibacterial spectrum.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Appl Microbiol       Date:  1971-11

9.  IN VITRO BIOLOGICAL ACTIVITY OF CEPHALOTHIN.

Authors:  T W CHANG; L WEINSTEIN
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

  9 in total
  1 in total

1.  In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.

Authors:  S Shadomy; G Wagner; M Carver
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.